Drug stocks follow Celgene south
December 06, 2010 at 10:50 AM EST
Celgene Corp. led drug stocks south early Monday, as shares of the biotech group fell in the wake of disappointing long-term survival data for its flagship drug Revlimid.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.